American Well (AMWL)
(Delayed Data from NYSE)
$7.01 USD
-0.34 (-4.63%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.90 -0.11 (-1.57%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AMWL 7.01 -0.34(-4.63%)
Will AMWL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMWL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMWL
American Well (AMWL) Soars 5.0%: Is Further Upside Left in the Stock?
The Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well
AMWL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Paves the Way for Global Digital Health Expansion
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors
Other News for AMWL
American Well: A Military Contract Renewal Could Make Or Break This Turnaround Story
American Well Holds Annual Stockholders Meeting
Hims & Hers Health Is Building The Next Global Primary-Care Network
Top Executive Sells Thousands of American Well Shares!
Teladoc Health: Under Observation, But Will Probably Pull Through